<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 32-year-old male dialysis patient with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:hpo ids='HP_0000123'>nephritis</z:hpo> was admitted because of shunt obstruction </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:hpo ids='HP_0004947'>arteriovenous fistula</z:hpo> was reconstructed, but obstruction recurred twice within several hours after surgery </plain></SENT>
<SENT sid="2" pm="."><plain>A high blood level of anticardiolipin beta2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I antibody suggested that shunt obstruction was caused by a thrombotic tendency related to the <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome </plain></SENT>
<SENT sid="3" pm="."><plain>Accordingly, for the third shunt procedure, antiplatelet therapy (which had been commenced for <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo>) was combined with dalteparin <z:chebi fb="199" ids="26708">sodium</z:chebi> from before surgery and <z:chebi fb="8" ids="10033">warfarin</z:chebi> was added postoperatively </plain></SENT>
<SENT sid="4" pm="."><plain>This regimen prevented shunt obstruction </plain></SENT>
<SENT sid="5" pm="."><plain>In conclusion, hemodialysis patients who suffer repeated shunt obstruction should be examined for <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome </plain></SENT>
</text></document>